A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive Pathogens
Autor: | Huang, David B., File, Thomas M., Jr, Torres, Antoni, Shorr, Andrew F., Wilcox, Mark H., Hadvary, Paul, Dryden, Matthew, Corey, G. Ralph |
---|---|
Zdroj: | In Clinical Therapeutics August 2017 39(8):1706-1718 |
Databáze: | ScienceDirect |
Externí odkaz: |